Spero Oncology Overview

  • Founded

  • 2014

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 11

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Spero Oncology General Information

Description

Operator of a clinical research organization (CRO) focused on development of oncology products. The company provides clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand.

Contact Information

Website
www.spero-oncology.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Pharmaceuticals
Acquirer
Veristat
Primary Office
  • Duart House 3 Finch Way
  • Strathclyde Business Park
  • Bellshill ML4 3PR
  • Scotland, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spero Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Spero Oncology‘s full profile, request access.

Request a free trial

Spero Oncology Executive Team (3)

Name Title Board Seat Contact Info
Theresa Bruce Founder & Managing Director
Kathryn Clayton Director, Clinical Operations
Grace Flynn Director, Contracts & Proposals
To view Spero Oncology’s complete executive team members history, request access »

Spero Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial